Contact Us  |  Site Map  |  Search  |  Client Login  
 
 
Boston Millennia Partners
   
  Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.  
 

Boston Millennia Partners is pleased to announce that its portfolio company, Odyssey Logistics & Technology Corporation, a leading global logistics provider, has achieved revenue growth in excess of 66% in 2011. Benefiting from solid organic growth as well as successfully integrating four recent acquisitions from April 2010 through January 2011, the Company is continuing its acquisition program in 2012. "Odyssey is benefiting from scale, as its larger transportation network enables it to lower costs to its customers. Also,” says Martin Hernon, a partner at Boston Millennia Partners and member of the Odyssey Board of Directors, “the company is an attractive acquisition partner for business owners, as Odyssey management strives to maintain a very fair and congenial culture for the companies that it acquires." Click Here to Read More


 
   
   

Boston Millennia Portfolio Company, MedAptus®, Announces Kennedy University Hospitalists Adopt MedAptus for Inpatient Charge Capture Automation
Millennia Portfolio Company, MedAptus, announces that Kennedy University Hospitalists recently completed implementation of the company’s Professional (Pro) Charge Capture solution.

Learn More >

Boston Millennia Partners Portfolio Company, CardioMEMS, Featured on CBS Evening News
A CBS News Boston special report features Millennia Portfolio Company, CardioMEMS', heart failure monitor in use at Brigham and Women's Hospital.

Learn More >

Boston Millennia Portfolio Company, MedAptus®, Expands Physician Revenue Cycle Suite with Cloud-Based Provider Enrollment Solution
MedAptus® announces the launch of MedAptus Provider Enrollment, the company’s latest software component aimed at addressing the challenge of timely and complete physician credentialing.

Learn More >

Boston Millennia Partners Portfolio Company, Odyssey Logistics & Technology Corp., Announces the Acquistion of ADS Logistics
Odyssey Logistics & Technology Corp., a leader in global supply chain logistics, announced the acquisition of Alternative Distribution Systems Logistics Company, Inc. (ADS Logistics), a full service metals logistics provider based out of Chesterton, Indiana.

Learn More >

PAREXEL International, Corp. Reports Fourth Quarter and Fiscal Year 2014 Results
PAREXEL International Corp. reports a 10.2% growth in consolidated service revenue to $510.6 million for Q42013 and an 11.8% growth in consolidated service revenue to $1.94 billion for the Fiscal Year 2014.

Learn More >

Millennia Portfolio Company, Collegium Pharmaceutical, Announces Positive Top-Line Data from Phase III Study of Oxycodone DETERx®
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced positive top-line results from its pivotal Phase 3 study of the company’s investigational analgesic Oxycodone DETERx® that studied the treatment of patients with moderate-to-severe chronic low back pain.

Learn More >

Millennia Portfolio Company, MedAptus, Announces Children’s National Health System Deploys MedAptus’ ICD-10 Solution Acrossits Outpatient Enterprise
MedAptus® today announced that Children’s National Health System has completed deployment of the company’s Pro and Tech solutions across its numerous outpatient care locations.

Learn More >

Dana Callow Featured on MassDevice
Managing Partner, Dana Callow, discusses the sale of portfolio company CardioMEMS to St. Jude Medical with MassDevice.

Learn More >

Boston Millennia Partners Congratulates PreCision Dermatology Management on $500 Million Sale to Valeant Pharmaceuticals International
With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals International, Inc. for $500 million, closed July 7, 2014.

Learn More >

Boston Millennia Portfolio Company, MedAptus, Announces First Coast Cardiovascular Institute Implemented Professional Charge Capture
First Coast Cardiovascular Institute (FCCI) has successfully implemented MedAptus’ Professional Charge Capture application and is experiencing significant improvement in efficiency. FCCI chose MedAptus based on functionality and strong track record of success in multi-specialty environment.

Learn More >

 
 
Click Here to receive news updates
from Boston Millennia Partners >



 
CEO Video Dana Callow on Bloomberg TV with Pimm Fox

Video: Click Here to View
CEO Video NECN CEO Corner Interview With Dana Callow

Video: Large | Small
CEO Video Dana Callow on PBS’s Greater Boston With Emily Rooney

Video: Large | Small
spacer
   
Healthcare information is becoming broadly available to consumers, which is expanding basic demand.
Learn More >
 
   
Three key areas of opportunity in the Life Sciences sector are drug discovery & development...
Learn More >
 
 
  | Our Firm      Our Team      Our Portfolio      Resources      News  
  © 2008 Boston Millennia Partners  All Rights Reserved